GUELPH, ON, Aug. 16, 2012 /CNW/ - BIOREM Inc. (TSXV:BRM) is pleased to announce the final closing of its
private placement. In the initial closing, a total of 1030 Units were
issued for gross proceeds of $1,030,000. Subsequently, an additional 86
Units were closed which brought the total units closed to 1,116 for
total gross proceeds of $1,116,000.
Each Unit consists of $1,000 principal amount of 8.00% convertible
extendible secured subordinated debentures (the "Debentures") with a maturity date 2 years from the date of issuance and 4,545
common share purchase warrants (the "Warrants"). The Debentures are convertible into fully paid and non-assessable
Common Shares of the Company at the option of the holder at any time
over their term at a price of $0.11 per Common Share. The maturity
date of the Debentures can be extended to the fifth anniversary date of
the issuance date of the Debentures by holders of 66.67% of the then
outstanding principal amount of Debentures. The Debentures can be
prepaid in full at any time by the Company upon giving holders 15 days
notice of prepayment. Each Warrant entitles the holder to purchase one
common share at a price of $0.11 per share for a period of two (2)
years from issuance. All securities issued pursuant to the Private
Placement will be subject to a four month hold pursuant to applicable
As noted in Biorem's July 25, 2012 press release announcing the closing
of the initial private placement, insiders have subscribed for greater
than 25% of the private placement. The issuance of Units to insiders
pursuant to the private placement is considered to be a related party
transaction subject to TSX Venture Exchange Policy 5.9 and Multilateral
Instrument 61-101. Biorem has relied on exemptions from the formal
valuation and minority shareholder approval requirements provided under
sections 5.5(c) and 5.7(b) of Multilateral Instrument 61-101 on the
basis that the private placement constitutes a distribution of
securities for cash to insiders which is within the parameters of those
BIOREM intends to use the proceeds from the private placement for
working capital and general corporate purposes.
About BIOREM Inc.
BIOREM is a leading clean technology company that designs, manufactures
and distributes a comprehensive line of high-efficiency air emissions
control systems used to eliminate odors, volatile organic compounds
(VOCs), and hazardous air pollutants (HAPs). With sales and
manufacturing offices across the continent, a dedicated research
facility, a worldwide sales representative network and more than 600
installed systems worldwide, BIOREM offers state-of-the-art
technology-based products and peace of mind for municipalities,
industrial companies and their surrounding communities. Additional
information on Biorem is available on our website at www.biorem.biz.
Neither TSX Venture Exchange nor its Regulation Services Provider (as
that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Biorem Inc.
For further information:
Peter Bruijns, Chief Executive Officer
Tel: (519) 767-9100